FDA
- Status: approved
🇺🇸 Monovalent OPV 2 week interval in United States
Monovalent OPV 2 week interval (Monovalent OPV 2 week interval) regulatory status in United States.
Marketing authorisation
Monovalent OPV 2 week interval in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Monovalent OPV 2 week interval approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Monovalent OPV 2 week interval in United States?
International Centre for Diarrhoeal Disease Research, Bangladesh is the originator. The local marketing authorisation holder may differ — check the official source linked above.